The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.
Luckily for you, our mission at StockStory is to help you make money and avoid losses by sorting the winners from the losers. Keeping that in mind, here are three stocks under $50 to swipe left on and some alternatives you should look into instead.
Revolve (RVLV)
Share Price: $20.22
Launched in 2003 by software engineers Michael Mente and Mike Karanikolas, Revolve (NYSE:RVLV) is a fashion retailer leveraging social media and a community of fashion influencers to drive its merchandising strategy.
Why Are We Out on RVLV?
- May need to improve its platform and marketing strategy as its 5.8% average growth in active customers underwhelmed
- Highly competitive market means it’s on the never-ending treadmill of sales and marketing spend
- Earnings growth underperformed the sector average over the last three years as its EPS grew by just 7.5% annually
At $20.22 per share, Revolve trades at 10.9x forward EV/EBITDA. Dive into our free research report to see why there are better opportunities than RVLV.
H&R Block (HRB)
Share Price: $38.64
Founded in 1955 by brothers Henry W. Bloch and Richard A. Bloch, H&R Block (NYSE:HRB) is a tax preparation company offering professional tax assistance and financial solutions to individuals and small businesses.
Why Do We Avoid HRB?
- Annual revenue declines of 2.1% over the last five years indicate problems with its market positioning
- Earnings growth over the last five years fell short of the peer group average as its EPS only increased by 8.8% annually
- Shrinking returns on capital suggest that increasing competition is eating into the company’s profitability
H&R Block’s stock price of $38.64 implies a valuation ratio of 1.2x forward price-to-sales. To fully understand why you should be careful with HRB, check out our full research report (it’s free).
Phibro Animal Health (PAHC)
Share Price: $33.13
With a portfolio of approximately 800 product lines serving farmers and veterinarians in 90 countries, Phibro Animal Health (NASDAQ:PAHC) develops, manufactures, and markets health products for livestock and companion animals, including antibacterials, vaccines, nutritional supplements, and mineral additives.
Why Are We Wary of PAHC?
- Modest revenue base of $1.5 billion gives it less fixed cost leverage and fewer distribution channels than larger companies
- Estimated sales growth of 2.2% for the next 12 months implies demand will slow from its two-year trend
- Low free cash flow margin of 0.8% for the last five years gives it little breathing room, constraining its ability to self-fund growth or return capital to shareholders
Phibro Animal Health is trading at $33.13 per share, or 10.4x forward P/E. Dive into our free research report to see why there are better opportunities than PAHC.
Stocks We Like More
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.